SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-22-000017
Filing Date
2022-05-09
Accepted
2022-05-09 17:20:41
Documents
75
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q egrx-20220331.htm   iXBRL 10-Q 1362766
2 EX-31.1 exhibit311q12022.htm EX-31.1 8479
3 EX-31.2 exhibit312q12022.htm EX-31.2 8438
4 EX-32.1 exhibit321q12022.htm EX-32.1 9041
  Complete submission text file 0000827871-22-000017.txt   6985339

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20220331.xsd EX-101.SCH 41113
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20220331_cal.xml EX-101.CAL 96482
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20220331_def.xml EX-101.DEF 185817
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20220331_lab.xml EX-101.LAB 603137
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20220331_pre.xml EX-101.PRE 376511
69 EXTRACTED XBRL INSTANCE DOCUMENT egrx-20220331_htm.xml XML 1224164
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 22906247
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences